The company's product is therapeutically equivalent to Otsuka Pharmaceutical Co's reference listed drug product Rexulti tablets, it added. Brexpiprazole tablets are indicated as an adjunctive therapy to antidepressants for the treatment of major depressive disorder and for the treatment of schizophrenia.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Uli0cIX
via IFTTT
0 comments:
Post a Comment